PhRMA pres warns against DTC moratorium

Share this article:
In a statement warning the Senate against imposing a moratorium on DTC, PhRMA president and CEO Billy Tauzin said: “DTC empowers patients by increasing their awareness of diseases and available treatments. Banning this information— even for just a couple of years—is not in the best interest of patients and physicians who every day make important healthcare decisions.”

Share this article:

Email Newsletters

More in News

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.

GSK, Novartis, Lilly play musical chairs

GSK, Novartis, Lilly play musical chairs

The three drugmakers rearranged part of the pharma universe Tuesday with a string of pipeline-altering deals.

Valeant bids $47B for Allergan

Valeant bids $47B for Allergan

The deal would bring Allergan's Botox and Juvederm under the same roof as Restylane.